Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /
The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Körperschaft: | |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Heidelberg :
Physica-Verlag HD : Imprint: Physica,
2006.
|
| Ausgabe: | 1st ed. 2006. |
| Schriftenreihe: | Contributions to Management Science,
|
| Schlagworte: | |
| Online Zugang: | https://doi.org/10.1007/3-7908-1668-X |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|